|
π
|
Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease
27 auth.
K. Poesen,
M. De Schaepdryver,
B. Stubendorff,
B. Gille,
P. MΕ―ΔkovΓ‘,
S. Wendler,
T. Prell,
T. Ringer,
H. Rhode,
Olivier Stevens,
K. Claeys,
Goedele Couwelier,
A. D'hondt,
N. Lamaire,
P. Tilkin,
...
Dimphna van Reijen,
S. Gourmaud,
N. Fedtke,
B. Heiling,
M. Rumpel,
A. RΓΆdiger,
A. Gunkel,
O. Witte,
C. Paquet,
R. Vandenberghe,
J. Grosskreutz,
P. van Damme
|
7 |
2017 |
7
π
|
|
π¦
|
Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis
13 auth.
B. Gille,
M. De Schaepdryver,
J. Goossens,
L. Dedeene,
Joke de Vocht,
E. Oldoni,
A. Goris,
L. Van Den Bosch,
B. Depreitere,
K. Claeys,
...
J. Tournoy,
P. van Damme,
K. Poesen
|
6 |
2018 |
6
π¦
|
|
π
|
Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
8 auth.
M. De Schaepdryver,
A. Jeromin,
B. Gille,
K. Claeys,
V. Herbst,
Britta Brix,
...
P. van Damme,
K. Poesen
|
6 |
2017 |
6
π
|
|
π¦
|
Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis?
9 auth.
B. Gille,
M. De Schaepdryver,
L. Dedeene,
J. Goossens,
K. Claeys,
L. Van Den Bosch,
...
J. Tournoy,
P. van Damme,
K. Poesen
|
6 |
2019 |
6
π¦
|
|
π
|
Comparison of ELISA- and SIMOA-based quantification of plasma AΞ² ratios for early detection of cerebral amyloidosis
15 auth.
Steffi De Meyer,
J. Schaeverbeke,
I. Verberk,
B. Gille,
M. De Schaepdryver,
E. S. Luckett,
S. Gabel,
R. Bruffaerts,
Kimberley Mauroo,
Elisabeth H Thijssen,
...
E. Stoops,
H. Vanderstichele,
C. Teunissen,
R. Vandenberghe,
K. Poesen
|
6 |
2020 |
6
π
|
|
π
|
Cerebrospinal fluid levels of synaptic and neuronal integrity correlate with gray matter volume and amyloid load in the precuneus of cognitively intact older adults
11 auth.
J. Schaeverbeke,
B. Gille,
Katarzyna Adamczuk,
H. Vanderstichele,
E. Chassaing,
R. Bruffaerts,
...
Veerle Neyens,
E. Stoops,
J. Tournoy,
R. Vandenberghe,
K. Poesen
|
3 |
2019 |
3
π
|
|
π¦
|
Automation on an Open-Access Platform of Alzheimerβs Disease Biomarker Immunoassays
12 auth.
B. Gille,
L. Dedeene,
E. Stoops,
L. Demeyer,
Cindy François,
S. Lefever,
...
M. De Schaepdryver,
Britta Brix,
R. Vandenberghe,
J. Tournoy,
H. Vanderstichele,
K. Poesen
|
2 |
2018 |
2
π¦
|
|
π
|
Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus
8 auth.
N. Vandenbussche,
C. Cassiman,
M. Schrooten,
B. Gille,
X. Bossuyt,
T. Vincent,
...
P. van Damme,
K. Poesen
|
0 |
2017 |
0
π
|
